Find Funding   Limited Submissions   Find Expertise  
  Limited Submissions
  NIH: Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2) RFA-AR-14-015

The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Leadership Center. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells.

USC may only submit one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White ( by April 4, 2014.. In addition to the 2-page abstract, you should also submit a biosketch for the PI.

NIH indicates that a letter of intent is due on April 21, 2014 and a full proposal is due by May 21, 2014. For more information:
Copyright © USC Office of Research & Graduate Education. Web Design by Tim Rodono.